Australia vs Lower-middle income (World Bank): Treatment success rate: XDR-TB cases
Australia
100
in 2022
Lower-middle income (World Bank)
73
in 2022
Australia rank
1st
Lower-middle income (World Bank) rank
2nd
Treatment success rate: XDR-TB cases over time
- Australia
- Lower-middle income (World Bank)
How they compare
Australia currently reports 100 against 73 in Lower-middle income (World Bank), a difference of 27.
That makes Australia's figure about 1.4 times Lower-middle income (World Bank)'s.
The two have swapped places 3 times across 7 shared years of data; in 2010 it was Lower-middle income (World Bank) ahead.
Australia ranks 1st and Lower-middle income (World Bank) ranks 2nd of 82 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.75 | 33.75 | 33 | Australia |
| 2020s | 77.67 | 69.33 | 8.33 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Australia or Lower-middle income (World Bank)?
- Australia, at 100 against 73 in Lower-middle income (World Bank) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Australia and Lower-middle income (World Bank)?
- 27, with Australia ahead.
- How many years of comparable data are there for Australia and Lower-middle income (World Bank)?
- 7 years are reported by both, from 2010 to 2022.
- How do Australia and Lower-middle income (World Bank) rank globally for treatment success rate: xdr-tb cases?
- Australia ranks 1st and Lower-middle income (World Bank) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.